Cargando…
Novel antibiotics: Are we still in the pre–post-antibiotic era?
PURPOSE: Therapeutic efficacy and safety in infections due to multidrug-resistant bacteria can be improved by the clinical development of new compounds and devising new derivatives of already useful antibiotics. Due to a striking global increase in multidrug-resistant Gram-positive but even more Gra...
Autores principales: | Draenert, R., Seybold, U., Grützner, E., Bogner, J. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382537/ https://www.ncbi.nlm.nih.gov/pubmed/25701222 http://dx.doi.org/10.1007/s15010-015-0749-y |
Ejemplares similares
-
Antimicrobial Peptides as Anti-Infective Agents in Pre-Post-Antibiotic Era?
por: Rončević, Tomislav, et al.
Publicado: (2019) -
In the era of broad spectrum antibiotics, is ampicillin still an option?
por: Popescu, Cristina, et al.
Publicado: (2013) -
Bacteriophages: Protagonists of a Post-Antibiotic Era
por: Domingo-Calap, Pilar, et al.
Publicado: (2018) -
Mining Actinomycetes for Novel Antibiotics in the Omics Era: Are We Ready to Exploit This New Paradigm?
por: Genilloud, Olga
Publicado: (2018) -
Carbonic Anhydrase Inhibitors as Novel Antibacterials in the Era of Antibiotic Resistance: Where Are We Now?
por: Nocentini, Alessio, et al.
Publicado: (2023)